Följ
Christopher B. Fox
Christopher B. Fox
SVP, Formulations, Access to Advanced Health Institute
Verifierad e-postadress på aahi.org
Titel
Citeras av
Citeras av
År
Key roles of adjuvants in modern vaccines
SG Reed, MT Orr, CB Fox
Nature medicine 19 (12), 1597-1608, 2013
13862013
Use of defined TLR ligands as adjuvants within human vaccines
MS Duthie, HP Windish, CB Fox, SG Reed
Immunological reviews 239 (1), 178-196, 2011
4992011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant
RN Coler, S Bertholet, M Moutaftsi, JA Guderian, HP Windish, SL Baldwin, ...
PloS one 6 (1), e16333, 2011
4002011
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
H HogenEsch, DT O’Hagan, CB Fox
npj Vaccines 3 (1), 51, 2018
3102018
Squalene emulsions for parenteral vaccine and drug delivery
CB Fox
Molecules 14 (9), 3286-3312, 2009
2572009
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
NPH Knudsen, A Olsen, C Buonsanti, F Follmann, Y Zhang, RN Coler, ...
Scientific reports 6 (1), 19570, 2016
2422016
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
KO Saunders, E Lee, R Parks, DR Martinez, D Li, H Chen, RJ Edwards, ...
Nature 594 (7864), 553-559, 2021
2242021
New generation adjuvants–from empiricism to rational design
DT O’Hagan, CB Fox
Vaccine 33, B14-B20, 2015
1782015
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
CB Fox, J Haensler
Expert review of vaccines 12 (7), 747-758, 2013
1512013
Detecting phase transitions in phosphatidylcholine vesicles by Raman microscopy and self-modeling curve resolution
CB Fox, RH Uibel, JM Harris
The Journal of Physical Chemistry B 111 (39), 11428-11436, 2007
1452007
A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika
JH Erasmus, AP Khandhar, J Guderian, B Granger, J Archer, M Archer, ...
Molecular Therapy 26 (10), 2507-2522, 2018
1312018
Working together: interactions between vaccine antigens and adjuvants
CB Fox, RM Kramer, L Barnes V, QM Dowling, TS Vedvick
Therapeutic advances in vaccines 1 (1), 7-20, 2013
1242013
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
RC Anderson, CB Fox, TS Dutill, N Shaverdian, TL Evers, GR Poshusta, ...
Colloids and Surfaces B: Biointerfaces 75 (1), 123-132, 2010
1222010
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
MT Orr, CB Fox, SL Baldwin, SJ Sivananthan, E Lucas, S Lin, T Phan, ...
Journal of controlled release 172 (1), 190-200, 2013
1122013
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates
SP Kasturi, MAU Rasheed, C Havenar-Daughton, M Pham, T Legere, ...
Science immunology 5 (48), eabb1025, 2020
1002020
Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions
CB Fox, RC Anderson, TS Dutill, Y Goto, SG Reed, TS Vedvick
Colloids and Surfaces B: Biointerfaces 65 (1), 98-105, 2008
972008
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
CB Fox, SJ Sivananthan, MS Duthie, J Vergara, JA Guderian, E Moon, ...
Journal of nanobiotechnology 12, 1-9, 2014
922014
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
SM Alam, B Aussedat, Y Vohra, RR Meyerhoff, EM Cale, WE Walkowicz, ...
Science translational medicine 9 (381), eaai7521, 2017
902017
Detection of drug− membrane interactions in individual phospholipid vesicles by confocal Raman microscopy
CB Fox, RA Horton, JM Harris
Analytical chemistry 78 (14), 4918-4924, 2006
902006
Adjuvants for Leishmania vaccines: from models to clinical application
VS Raman, MS Duthie, CB Fox, G Matlashewski, SG Reed
Frontiers in immunology 3, 144, 2012
892012
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20